Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 61.46 | 13.14 |
| PEG Ratio (TTM) | 1.93 | -1.37 |
| P/S Ratio (TTM) | 10.71 | 10.42 |
| P/B Ratio (TTM) | 1.28 | 1.44 |
| P/FCF Ratio (TTM) | 18.96 | 10.21 |
| Price to 5YR AVG Earnings Ratio | 39.12 | 21.27 |
| Price to 5YR AVG FCF Ratio | -21.33 | 42.34 |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.58% | 17.94% |
| ROE (TTM) | 2.10% | -1.09% |
| Net Profit Margin (TTM) | 17.45% | -5.48% |
| ROIC 5YR AVG | 3.63% | 11.03% |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2,668.72% | 85.95% | 67.20% |
| Revenue | -4.04% | 16.58% | 20.45% |
| Net Income | 2,567.19% | 87.81% | 80.07% |
| Cash Flow | -8.04% | 20.40% | 20.89% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.99 | 4.35 |
| Quick Ratio (TTM) | 1.99 | 2.95 |
| D/E Ratio (TTM) | 0.27 | 0.02 |
| Interest Coverage (TTM) | 1.58 | 69.70 |
| Piotroski F-Score | 8 | 5 |
| Altman Z-Score | 2.88 | 9.35 |
| LTL to 5YR AVG FCF | -5.04 | -11.85 |
| Shares Outstanding Growth 5YR AVG | 10.74% | 14.30% |